News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
News CSL’s Hemgenix is first haemophilia B gene therapy in EU Firm will work with payers to try to secure access for as many patients across EU as possible.
News Travere undercuts key rival in rare kidney disease IgAN Filspari will launch for IgA Nepropathy at a discount to Calliditas' Tarpeyo, cleared in 2021.
News FDA undoes Astellas’ bid for fast review of menopause drug Pharma company had used a priority review voucher to speed up review of fezolinetant.
News Apellis breaks new ground in geographic atrophy Syfovre is the first FDA-approved drug for GA, which damages the sight of 5m people worldwide.
News FDA gives green light to Chiesi's Lamzede Chiesi scores milestone US FDA approval for first AM enzyme replacement therapy, Lamzede.
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
